News & Views

The MHRA published its 2030 Strategy on 14 October 2026. It sets out how UK regulation of medicines, devices and AI will change over the next five years, with patient safety, faster access and scientific excellence at its centre.  Much of the coverage has focused on timelines and AI. For insight and evidence teams, the …

Continue reading “MHRA Strategy 2030: what it means for insight and evidence”

Our Porterhouse Medical team will be at the International Congress of Infectious Diseases (ICID). This year’s congress takes place in Madrid from 10 to 13 November.  The International Society for Infectious Diseases’ flagship meeting will  cover all fields of infection within a One Health context, from clinical practice and translational science to infection prevention and …

Continue reading “Meet our team at ICID 2026 in Madrid”

Our team is heading to Denver to the Annual congress of the American Association for the Study of Liver Diseases (AASLD). Known as the “Liver Meeting”, the event brings together hepatology researchers, clinicians and industry scientists to share the latest clinical and translational research across liver disease. This year the congress runs from 5 to …

Continue reading “Porterhouse Medical will be at the Liver Meeting, Denver”

Our team will be attending ESMO in Madrid from 23 to 27 October, the European Society for Medical Oncology’s annual meeting.   The congress brings together clinicians, researchers, patient advocates and industry from around the world to share the latest advances in cancer research, clinical practice and patient care.  With deep experience in oncology, our team …

Continue reading “Join us at ESMO 2026 in Madrid”

Our Porterhouse Medical team is attending the Kidney Week congress in Denver from 22 to 25 October, supporting pharmaceutical clients across their scientific communications programmes.   Kidney Week is the American Society of Nephrology’s annual meeting, bringing together nephrologists, researchers and kidney health professionals to share the latest science and clinical advances in kidney medicine.  Whether …

Continue reading “Supporting scientific communications at Kidney Week 2026, Denver”

The World Stroke Congress is the World Stroke Organisation’s annual meeting, bringing together clinicians, researchers, nurses, rehabilitation specialists and patient advocates to share the latest advances in stroke prevention, acute treatment, recovery and rehabilitation.  This year’s 18th congress takes place in Seoul from 21 to 23 October, held jointly with the International Conference Stroke Update …

Continue reading “Porterhouse Medical to attend World Stroke Congress 2026, Korea”

UEG Week is United European Gastroenterology’s annual congress, bringing together digestive health experts from around the world to share the latest research across gastroenterology, hepatology, endoscopy and related fields.  Our Porterhouse Medical team will be in Barcelona from 17 to 20 October, supporting pharmaceutical organisations across their scientific communications programmes.   We partner with clients …

Continue reading “Porterhouse Medical at UEG Week 2026 in Barcelona”

Last week, members of our Porterhouse Medical team were in Vienna for EURETINA 2026, supporting pharmaceutical partners across their scientific communications programmes. Throughout the congress, our congress surveillance kept track of emerging data and competitor activity, giving our clients a clear view of the landscape to take into their post-congress planning. Planning for an upcoming …

Continue reading “Our team attended EURETINA 2026 in Vienna”

As the global incidence of Alzheimer’s disease continues to rise, predicted to reach 139 million by 2050 [1], the need for effective treatments has never been greater. This urgency is reflected in the estimated $42 billion spent on Alzheimer’s research and development over the past three decades [2], yet there remains no cure. As part …

Continue reading “World Alzheimer’s Month: Where are we in the search for a cure?”

A phase two readout lands. Weeks later, in your first regulatory meeting, you discover the new joint clinical assessment process requires comparator data you don’t have. The trial has already finished enrolling. There’s no going back to fix the design.  It’s the scenario that opens episode one of The Value Equation, our new podcast on …

Continue reading “Introducing The Value Equation: a new podcast from SCIRIS Group”

Alzheimer’s disease (AD) is a chronic and progressive neurodegenerative disease that accounts for 60%–70% of all cases of dementia globally. As the number of people with AD is projected to reach 106 million by 2050, research has increasingly focused on moving beyond symptomatic treatment to target the underlying disease aetiology itself [1]. As we enter …

Continue reading “World Alzheimer’s Month: How well do we know the disease?”

April is Parkinson’s Awareness Month, a time dedicated to highlighting the growing global impact of Parkinson’s and the urgent need for greater awareness, earlier diagnosis and improved support for those living with the condition [1]. Parkinson’s is one of the fastest growing neurological disorders worldwide, with prevalence increasing rapidly owing to ageing populations and improved …

Continue reading “From neurons to needs: Parkinson’s Awareness Month”